Vanarix has developed a new generation of cell therapy to produce high-quality hyaline cartilage mini-grafts, named Cartibeads, which resemble native tissue. Cartibeads are bio-engineered cartilage implant made from allogeneic chondrocytes.
When implanted during minimally invasive arthroscopic surgery, Cartibeads can completely self-integrate into cartilage lesions and thus regenerate the tissue. Cartibeads are designed for the treatment of cartilage defects in traumatic and osteoarthritic joints.
#cartilagerepair
#cartilageregeneration
#celltherapy
#kneerepair
#osteoarthritis
Company Details
- Employees
- 3
- Founded
- -
- Address
- Avenue Mon-Repos 14, Lausanne,vaud (Fr) 1005,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Lausanne, Vaud (fr)
Vanarix Questions
Vanarix's website is https://www.vanarix-cartilage-regeneration.ch/
Vanarix's LinkedIn profile is https://ch.linkedin.com/company/vanarix
Vanarix has
3 employees.
View email and phone details for 3
employees at Vanarix.
Vanarix's industry is
Biotechnology Research
Vanarix's top competitors are
Biospectal Sa,
Vandria Sa,
Comphya,
Nagi Bioscience,
Xsensio,
Adularia,
Lymphatica Medtech,
Adaptyv,
Alithea Genomics,
Neural Concept.
Vanarix's categories are Biotechnology Research
Vanarix's founding year is 2018
